<VariationArchive VariationID="3027420" VariationName="NM_033380.3(COL4A5):c.4455_4465del (p.Thr1486fs)" VariationType="Deletion" Accession="VCV003027420" Version="1" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-06-23" DateCreated="2024-03-11" MostRecentSubmission="2024-03-10">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="3187729" VariationID="3027420">
      <GeneList>
        <Gene Symbol="COL4A5" FullName="collagen type IV alpha 5 chain" GeneID="1287" HGNC_ID="HGNC:2207" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>Xq22.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="108439838" stop="108697545" display_start="108439838" display_stop="108697545" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="107683073" stop="107940774" display_start="107683073" display_stop="107940774" Strand="+" />
          </Location>
          <OMIM>303630</OMIM>
          <Haploinsufficiency last_evaluated="2020-09-08" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=COL4A5">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2020-09-08" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=COL4A5">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_033380.3(COL4A5):c.4455_4465del (p.Thr1486fs)</Name>
      <CanonicalSPDI>NC_000023.11:108687618:GGAACACTTCAGG:GG</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>Xq22.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="108687619" stop="108687629" display_start="108687619" display_stop="108687629" variantLength="11" positionVCF="108687618" referenceAlleleVCF="GGGAACACTTCA" alternateAlleleVCF="G" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="107930849" stop="107930859" display_start="107930849" display_stop="107930859" variantLength="11" positionVCF="107930848" referenceAlleleVCF="GGGAACACTTCA" alternateAlleleVCF="G" />
      </Location>
      <ProteinChange>T1480fs</ProteinChange>
      <ProteinChange>T1486fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.10" sequenceAccession="NC_000023" sequenceVersion="10" change="g.107930851_107930861del" Assembly="GRCh37">
            <Expression>NC_000023.10:g.107930851_107930861del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.11" sequenceAccession="NC_000023" sequenceVersion="11" change="g.108687621_108687631del" Assembly="GRCh38">
            <Expression>NC_000023.11:g.108687621_108687631del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_011977.2" sequenceAccession="NG_011977" sequenceVersion="2" change="g.252698_252708del">
            <Expression>NG_011977.2:g.252698_252708del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000495.5" sequenceAccession="NM_000495" sequenceVersion="5" change="c.4437_4447del">
            <Expression>NM_000495.5:c.4437_4447del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000486.1" sequenceAccession="NP_000486" sequenceVersion="1" change="p.Thr1480fs">
            <Expression>NP_000486.1:p.Thr1480fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_033380.3" sequenceAccession="NM_033380" sequenceVersion="3" change="c.4455_4465del" MANESelect="true">
            <Expression>NM_033380.3:c.4455_4465del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_203699.1" sequenceAccession="NP_203699" sequenceVersion="1" change="p.Thr1486fs">
            <Expression>NP_203699.1:p.Thr1486fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000495.5" sequenceAccession="NM_000495" sequenceVersion="5" change="c.4435_4445del">
            <Expression>NM_000495.5:c.4435_4445del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_232" sequenceAccession="LRG_232">
            <Expression>LRG_232:g.252698_252708del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_232t1" sequenceAccession="LRG_232t1">
            <Expression>LRG_232t1:c.4437_4447del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_232p1" sequenceAccession="LRG_232p1" change="p.Thr1480fs">
            <Expression>LRG_232p1:p.Thr1480fs</Expression>
          </ProteinExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_232t2" sequenceAccession="LRG_232t2">
            <Expression>LRG_232t2:c.4455_4465del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_232p2" sequenceAccession="LRG_232p2" change="p.Thr1486fs">
            <Expression>LRG_232p2:p.Thr1486fs</Expression>
          </ProteinExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_033380.3(COL4A5):c.4455_4465del (p.Thr1486fs) AND Alport syndrome" Accession="RCV003887813" Version="2">
        <ClassifiedConditionList TraitSetID="6750">
          <ClassifiedCondition DB="MedGen" ID="C1567741">Alport syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2024-03-11" MostRecentSubmission="2024-03-10">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="DOI">10.2215/CJN.01030209</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="6750" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="13255" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Alport syndrome</ElementValue>
                <XRef ID="MONDO:0018965" DB="MONDO" />
                <XRef Type="Phenotypic series" ID="PS301050" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hemorrhagic familial nephritis</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hemorrhagic hereditary nephritis</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Congenital hereditary hematuria</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="5785" />
                <XRef ID="5785" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="63" DB="Orphanet" />
              <XRef ID="C1567741" DB="MedGen" />
              <XRef ID="MONDO:0018965" DB="MONDO" />
              <XRef Type="Phenotypic series" ID="PS301050" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="8778940" SubmissionDate="2024-03-06" DateLastUpdated="2024-03-10" DateCreated="2024-03-10">
        <ClinVarSubmissionID localKey="COL4A5(c.4435 _4445del)" submittedAssembly="GRCh37" title="COL4A5(c.4435 _4445del)" />
        <ClinVarAccession Accession="SCV004698204" DateUpdated="2024-03-10" DateCreated="2024-03-10" Type="SCV" Version="1" SubmitterName="Department of Traditional Chinese Medicine, Fujian Provincial Hospital" OrgID="506270" OrganizationCategory="clinic" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation Type="general">
            <ID Source="DOI">10.2215/CJN.01030209</ID>
          </Citation>
          <Comment>We identified mutant c.4435_4445del:p.Thr1480Leufs* 2 in a man with Alport syndrome, which produces truncated proteins and thus causes disease. His renal pathology suggested focal foamy cells in the renal interstitium, and type IV collagen staining was negative for both α 3 and α 5, suggesting an X-linked Alport syndrome kidney injury. According to The American College of Medical Genetics and Genomics (ACMG) guidelines, the mutation was consistent with PVS1_Strong (Null variant in a gene where loss of function (LOF) is a known mechanism of disease.) + PS2 (De novo in a patient with the disease and no family history.) + PM2_Supporting (Absent from controls in Exome Sequencing Project, 1000 Genomes or ExAC.), so we considered the mutation to be pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>research</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="COL4A5">
              <Name>collagen type IV alpha 5 chain</Name>
            </Gene>
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000495.5:c.4435_4445del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="Orphanet" ID="ORPHA63" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>COL4A5(c.4435 _4445del)</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="8778940" TraitType="Disease" MappingType="XRef" MappingValue="ORPHA63" MappingRef="Orphanet">
        <MedGen CUI="C1567741" Name="Alport syndrome" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

